Top-News

NEUROTROPE, INC. News

Keine aktuellen Kursdaten verfügbar
ISIN: US64129T1088
Typ: Aktie

NEUROTROPE, INC. News

27.03.17 - PR Newswire
Neurotrope, Inc. Announces Approval for Listing on the NASDAQ Capital Market
Neurotrope, Inc. Announces Approval for Listing on the NASDAQ Capital Market Begins Trading on the NASDAQ Capital Market on March 29, 2017. Neurotrope Will Ring the Opening ...
24.03.17 - PR Newswire
Neurotrope's President and Chief Scientific Officer to Present Keynote Address at Sachs Associates' 2nd Annual Neuroscience Biopartnering & Investment Forum
Neurotrope's President and Chief Scientific Officer to Present Keynote Address at Sachs Associates' 2nd Annual Neuroscience Biopartnering & Investment Forum Dr. Alkon to ...
16.03.17 - PR Newswire
Neurotrope BioScience to Present at the Oppenheimer 27th Annual Healthcare Conference
Neurotrope BioScience to Present at the Oppenheimer 27th Annual Healthcare Conference PR Newswire
08.02.17 - PR Newswire
Neurotrope Bioscience to Present at the 19th Annual BIO CEO & Investor Conference 2017
Neurotrope Bioscience to Present at the 19th Annual BIO CEO & Investor Conference 2017 PR Newswire
27.01.17 - PR Newswire
Neurotrope Bioscience to Present at the Noble Financial Capital Markets' 13th Annual Investor Conference
Neurotrope Bioscience to Present at the Noble Financial Capital Markets' 13th Annual Investor Conference PR Newswire
12.01.17 - PR Newswire
Neurotrope Announces Reverse Split of Common Stock in Preparation for NASDAQ Uplisting
Neurotrope Announces Reverse Split of Common Stock in Preparation for NASDAQ Uplisting PR Newswire
05.01.17 - PR Newswire
Neurotrope to Present at Two Upcoming Investor Conferences
Neurotrope to Present at Two Upcoming Investor Conferences PR Newswire
23.11.16 - PR Newswire
Neurotrope Issues Statement On Eli Lilly's Solanezumab
Neurotrope Issues Statement On Eli Lilly's Solanezumab PR Newswire
18.11.16 - PR Newswire
Neurotrope Announces Private Placement of $20 Million
Neurotrope Announces Private Placement of $20 Million - Funding to complete Phase 2 trial in Alzheimer's with top line results expected April 2017 - Initiate clinical trial for Fragile X ...
28.09.16 - PR Newswire
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.
Dr. Daniel Alkon Appointed President of Neurotrope, Inc. PR Newswire
06.09.16 - PR Newswire
Susanne Wilke, PhD Appointed Chief Executive Officer of Neurotrope, Inc.
Susanne Wilke, PhD Appointed Chief Executive Officer of Neurotrope, Inc. PR Newswire
06.09.16 - PR Newswire
Susanne Wilke, PhD Appointed Chief Executive Officer of Neurotrope, Inc.
Susanne Wilke, PhD Appointed Chief Executive Officer of Neurotrope, Inc. PR Newswire
05.08.16 - PR Newswire
Neurotrope Announces Changes to the Board of Directors and Management
Neurotrope Announces Changes to the Board of Directors and Management Reaches Agreement with Iroquois Master Fund PR Newswire
23.06.16 - PR Newswire
Neurotrope announces that a new study published in the Journal of Biological Chemistry shows that Bryostatin, a PKC epsilon Activator, Generates New Synapses Through Accumulation of the Synaptic Ancho
Neurotrope announces that a new study published in the Journal of Biological Chemistry shows that Bryostatin, a PKC epsilon Activator, Generates New Synapses Through ...
21.06.16 - PR Newswire
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer PR Newswire
13.06.16 - PR Newswire
Neurotrope's Chief Scientific Officer Dr. Daniel Alkon Presents at the Gordon Conference: Drugs That Target Common Mechanisms for Synaptic Restoration in Mental Retardation and Alzheimer's Disease
Neurotrope's Chief Scientific Officer Dr. Daniel Alkon Presents at the Gordon Conference: Drugs That Target Common Mechanisms for Synaptic Restoration in Mental Retardation ...
08.03.16 - PR Newswire
Neurotrope Announces Publication Demonstrating Synaptic Regeneration with the PKC epsilon Activator Bryostatin, in a Fragile X Disease Late Brain Development Model
Neurotrope Announces Publication Demonstrating Synaptic Regeneration with the PKC epsilon Activator Bryostatin, in a Fragile X Disease Late Brain Development Model Bryostatin, ...
20.07.15 - PR Newswire
Neurotrope to Showcase Bryostatin as a Potential Treatment for Alzheimer's Disease at the 2015 Alzheimer's Association International Conference
Neurotrope to Showcase Bryostatin as a Potential Treatment for Alzheimer's Disease at the 2015 Alzheimer's Association International Conference PR Newswire
20.08.14 - PR Newswire
Neurotrope To Host Conference Call
Neurotrope To Host Conference Call Will Provide Business Update on Tuesday, August 26, 2014 PR Newswire
18.08.14 - PR Newswire
Neurotrope's Approach to Treating Alzheimer's Disease Through Its Product Bryostatin-1, an Activator of Protein Kinase C Epsilon (PKCe), Supported by Blanchette Rockefeller Neurosciences Institute (BR
Neurotrope's Approach to Treating Alzheimer's Disease Through Its Product Bryostatin-1, an Activator of Protein Kinase C Epsilon (PKCe), Supported by Blanchette Rockefeller ...

Newssuche

Videos

09:30 Uhr +34,15%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »